refractory myasthenia gravis
Information
- Disease name
- refractory myasthenia gravis
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00619671 | Completed | Phase 1/Phase 2 | A Pilot Trial of Rituxan in Refractory Myasthenia Gravis | April 2004 | March 2009 |
| NCT05332587 | Unknown status | Phase 3 | Efficacy and Safety of Low-dose Rituximab in the Treatment of Refractory Myasthenia Gravis | August 1, 2020 | July 1, 2022 |